Genetic Analysis of Epstein-Barr Virus Latent Membrane Protein 1 and Immunohistochemical Expression of Transforming Growth Factor (TGF)-¥â1, TGF-¥âRII, p21, p16, E2F1, Thymidylate Synthase, and NF-¥êB in Epstein-Barr Virus Encoded RNA-positive Gastric Adenoc
Á¶¹Ì¿¬, ±è´ë¼º, ÃÖ¼±ÁÖ, ¾ö¹Î¼·, ±è¸í¼ö, ¹Ú±¤ÇÏ, Kim Mee-Dong, Sung Seung-Hoon,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶¹Ì¿¬ ( Cho Mee-Yon )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è´ë¼º ( Kim Dae-Sung )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖ¼±ÁÖ ( Choi Sun-Ju )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
¾ö¹Î¼· ( Eum Min-Seob )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è¸í¼ö ( Kim Myoung-Soo )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹Ú±¤ÇÏ ( Park Kwang-Hwa )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
( Kim Mee-Dong )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
( Sung Seung-Hoon )
¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
KMID : 0357920060400030176
Abstract
Background: Although clinicopathologic differences have been described between Epstein-Barr virus (EBV)-positive and negative gastric adenocarcinomas, the pathogenetic basis for these differences remains unclear. In this study, efforts were made to confirm that expression of EBV-latent membrane protein (LMP1) and immunohistochemical characteristics of EBV-positive gastric adenocarcinomas.
Methods: We investigated genomic deletion, and RNA & protein expression of the EBV-LMP1, as well as immunohistochemical protein expression of transforming growth factor (TGF)-¥â1, TGF-¥âRII, p21, p16, E2F1, thymidylate synthase, and NF-¥êB in relation to EBV positive gastric adenocarcinoma.
Results: A total of 38 Epstein-Barr Virus Encoded RNA-positive and 80 negative gastric carcinomas were examined. A 30 bp DNA deletion in the EBV-LMP1 gene, initiating at codon 342, was detected in 94.4% of EBV-positive cases. By RT-PCR and western blotting, EBV-LMP1 mRNA and protein expressions were absent in all cases, re- gardless of DNA deletion. No significant differences in TGF-¥â1, TGF-¥âRII, p21, NF-¥êB, E2F1, or thymidylate synthase expression were identified. However, the decreased expression of p16 was found in 84.2% of EBV-positive carcinomas, relative to only 57.5% of EBV-negative tumors (p=0.024).
Conclusion: EBV-LMP1 DNA deletion, mRNA and protein losses are highly prevalent in EBV-positive gastric adenocarcinoma among Korean patients, along with decreased p16 expression.
Å°¿öµå
Stomach neoplasms;Epstein-Barr virus;EBV-Associated Membrane Antigen;Protein p16
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸